Mercaptopurine and Hypertriglyceridaemia - a phase IV clinical study of FDA data
Hypertriglyceridaemia is found among people who take Mercaptopurine, especially for people who are male, 10-19 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Mercaptopurine and have Hypertriglyceridaemia. It is created by eHealthMe based on reports of 17,723 people who have side effects when taking Mercaptopurine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
17,723 people reported to have side effects when taking Mercaptopurine.
Among them, 141 people (0.8%) have Hypertriglyceridaemia.
What is Mercaptopurine?
Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 17,983 Mercaptopurine users for its effectiveness, alternative drugs and more.
What is Hypertriglyceridaemia?
Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 1,091 drugs and 653 conditions by eHealthMe.
Number of Mercaptopurine and Hypertriglyceridaemia reports submitted per year:
Time on Mercaptopurine when people have Hypertriglyceridaemia *:
Gender of people who have Hypertriglyceridaemia when taking Mercaptopurine*:
Age of people who have Hypertriglyceridaemia when taking Mercaptopurine *:
Common drugs people take besides Mercaptopurine *:
Common side effects people have besides Hypertriglyceridaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mercaptopurine and have Hypertriglyceridaemia?Check whether Hypertriglyceridaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Mercaptopurine:
- Mercaptopurine (17,983 reports)
Hypertriglyceridaemia treatments and more:
- Hypertriglyceridaemia (10,974 reports)
COVID vaccines that are related to Hypertriglyceridaemia:
- Hypertriglyceridaemia in Moderna COVID Vaccine
- Hypertriglyceridaemia in Pfizer BioNTech Covid Vaccine
- Hypertriglyceridaemia in Johnson and Johnson Covid Vaccine
How severe was Hypertriglyceridaemia and when was it recovered:
Expand to all the drugs that have ingredients of mercaptopurine:
Common drugs associated with Hypertriglyceridaemia:
All the drugs that are associated with Hypertriglyceridaemia:
- Hypertriglyceridaemia (1,091 drugs)
Common conditions associated with Hypertriglyceridaemia:
All the conditions that are associated with Hypertriglyceridaemia:
- Hypertriglyceridaemia (653 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mercaptopurine (the active ingredients of Mercaptopurine) and Mercaptopurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urispas and Depakote drug interaction - 5 seconds ago
- Haloperidol and Pradaxa drug interaction - 6 seconds ago
- Skin Infection Aggravated and Adverse Event - 8 seconds ago
- Brilinta and Xyzal drug interaction - 15 seconds ago
- Hypoglycaemia Aggravated and Upper Respiratory Tract Infection - 16 seconds ago